Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Share-based Compensation (2018 - 2026)

Health Catalyst filings provide 9 years of Share-based Compensation readings, the most recent being $3.8 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 50.02% to $3.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $23.2 million, a 36.91% decrease, with the full-year FY2025 number at $27.0 million, down 32.69% from a year prior.
  • Share-based Compensation hit $3.8 million in Q1 2026 for Health Catalyst, down from $4.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $18.7 million in Q4 2022 to a low of $3.8 million in Q1 2026.
  • Median Share-based Compensation over the past 5 years was $10.8 million (2024), compared with a mean of $11.7 million.
  • Biggest five-year swings in Share-based Compensation: surged 34.12% in 2022 and later tumbled 62.01% in 2025.
  • Health Catalyst's Share-based Compensation stood at $18.7 million in 2022, then tumbled by 30.6% to $13.0 million in 2023, then fell by 16.9% to $10.8 million in 2024, then tumbled by 62.01% to $4.1 million in 2025, then decreased by 8.21% to $3.8 million in 2026.
  • The last three reported values for Share-based Compensation were $3.8 million (Q1 2026), $4.1 million (Q4 2025), and $7.0 million (Q3 2025) per Business Quant data.